BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|September 7, 2019
- September 2019 Pain Management
- Volume 85
- Issue 9
The Pharmacist's Critical Role in Antimicrobial Stewardship
Understanding the pharmacist's role in antimicrobial stewardship
Advertisement
Faculty
Monica Shah, PharmD, Clinicla Pharmacist, Monmouth Medical Center, Long Branch, New Jersey
Educational Objectives
At the completion of this activity, the participant will be able to:
- Explain the progression of antibiotic resistance as a global crisis and its impact on health care costs and patient outcomes
- Identify the most prominent MDR gram-negative pathogens and emerging treatment options
- Develop targeted strategies for an effective antimicrobial stewardship program within an institution
Target audience: Health-system and community pharmacists
Activity type: Application
Release date: September 16, 2019
Expiration date: September 16, 2020
Estimated time to complete activity: 2.0 hours
Fee: This lesson is offered for free at
Articles in this issue
about 7 years ago
Keep an Eye on Protein Kinase Inhibitorsabout 7 years ago
OTC Focus Case Studies: Painabout 7 years ago
What Are the Options for Treating Pain?about 7 years ago
Education, Law Enforcement, and Treatment Programs Are Keyabout 7 years ago
Dispensing Mistakes Can Happen to Pets, Tooabout 7 years ago
MRPs Are Both a Blessing and a Curseabout 7 years ago
Pharmacists Can Provide Optimal Migraine Treatmentsabout 7 years ago
Melrose Pharmacy Offers a Unique Feelabout 7 years ago
Topical Analgesics Provide Pain Reliefabout 7 years ago
Case Studies (September 2019)Advertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Statin Myths: Why Patients Avoid Cholesterol-Lowering Therapy
2
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
5